Belgium Ophthalmic Surgical Devices Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Belgium Ophthalmic Surgical Devices Market Size

• The Belgium ophthalmic surgical devices market size was valued at USD 60.81 million in 2025 and is expected to reach USD 70.69 million by 2033, at a CAGR of 1.9% during the forecast period
• The market growth is largely fueled by ongoing technological advancements in imaging and surgical instruments, increased innovation in intraocular lenses (IOLs) and refractive surgery devices, and a rising prevalence of eye diseases driving demand for advanced surgical solutions across hospitals and eye clinics in Belgium
• Furthermore, growing consumer demand for effective, precise, and minimally invasive ophthalmic surgical interventions and the introduction of novel products by key manufacturers are establishing ophthalmic surgical devices as essential tools in modern eye care. These converging factors are accelerating market uptake, thereby significantly boosting the industry’s growth trajectory

Belgium Ophthalmic Surgical Devices Market Analysis

• Ophthalmic surgical devices, including intraocular lenses (IOLs), surgical microscopes, phacoemulsification systems, and diagnostic instruments, are increasingly vital components of modern eye care and surgical procedures in hospitals and specialized eye clinics due to their precision, minimally invasive capabilities, and integration with advanced imaging technologies
• The escalating demand for ophthalmic surgical devices is primarily fueled by the growing prevalence of eye disorders such as cataracts, glaucoma, retinal diseases, and refractive errors, rising geriatric population, and increasing awareness of advanced surgical interventions among patients and healthcare providers
• Belgium’s ophthalmic surgical devices market is supported by well-established healthcare infrastructure, favorable reimbursement policies, and high adoption of technologically advanced instruments in leading hospitals and eye clinics, ensuring precise and efficient surgical outcomes across the country
• The market is also benefiting from increasing investments by medical device companies in clinical training, surgeon education, and local distribution networks, strengthening adoption of innovative ophthalmic surgical solutions across the country
• The cataract surgery devices segment dominated the market with a share of 45.6% in 2025, reflecting their essential role in addressing the high prevalence of cataract cases and ongoing innovations enhancing surgical precision and patient outcomes

Report Scope and Belgium Ophthalmic Surgical Devices Market Segmentation 

Belgium Ophthalmic Surgical Devices Market Trends

“Advancements in Minimally Invasive and Laser-Assisted Surgeries”

• A significant and accelerating trend in the Belgium ophthalmic surgical devices market is the increasing adoption of minimally invasive and laser-assisted surgical technologies, enhancing precision, reducing recovery times, and improving patient outcomes
• For instance, femtosecond laser-assisted cataract surgery systems are now being integrated into leading Belgian eye clinics, allowing surgeons to perform more precise corneal incisions and lens fragmentation with improved visual results
• Advanced imaging integration in surgical devices enables real-time monitoring of surgical procedures and improves accuracy in intraocular lens placement, enhancing safety and patient satisfaction. For instance, optical coherence tomography (OCT) guided systems allow precise retinal surgeries with reduced complications
• The seamless integration of advanced ophthalmic devices with hospital digital systems facilitates centralized surgical planning and patient monitoring, streamlining workflows and increasing operational efficiency
• This trend towards more precise, less invasive, and technologically integrated surgical solutions is reshaping surgeon expectations and patient care standards. For instance, companies such as Alcon and Zeiss are developing laser-assisted platforms with real-time imaging and automated guidance to enhance surgical outcomes
• The demand for advanced surgical systems that improve procedural accuracy, reduce complications, and optimize recovery time is growing rapidly across Belgian hospitals and specialty eye clinics, as patients increasingly seek high-quality vision care
• There is also a growing trend toward portable and compact surgical devices that allow smaller clinics and outpatient centers to perform complex procedures efficiently. For instance, mobile phacoemulsification units are being deployed in community eye care facilities

Belgium Ophthalmic Surgical Devices Market Dynamics

Driver

“Increasing Prevalence of Eye Disorders and Aging Population”

• The growing prevalence of cataracts, glaucoma, retinal diseases, and other ocular conditions, combined with an aging population, is a significant driver of demand for ophthalmic surgical devices in Belgium
• For instance, the Belgian National Institute for Health reported rising cataract and glaucoma cases among older adults, prompting hospitals to invest in modern surgical equipment to meet patient needs
• As awareness of effective treatment options increases, patients and healthcare providers are seeking advanced devices that enable safer, more efficient surgeries with better visual outcomes
• Furthermore, the expansion of eye care infrastructure and high adoption of technology-driven surgical instruments in leading hospitals reinforce the demand for sophisticated ophthalmic surgical devices
• The ability to deliver precise, minimally invasive procedures and improved post-operative recovery has positioned ophthalmic surgical devices as critical investments for hospitals and clinics. For instance, femtosecond lasers and phacoemulsification devices are increasingly deployed across Belgian eye centers
• Rising government and private funding for eye care research and technology adoption is further encouraging hospitals to upgrade their surgical devices. For instance, grants have supported deployment of high-precision imaging and laser platforms in major Belgian hospitals
• Increased patient willingness to pay for premium eye care services, particularly for vision correction and cataract surgeries, is driving demand for advanced devices. For instance, clinics offering laser-assisted surgeries have reported higher patient intake and satisfaction rates

Restraint/Challenge

“High Device Cost and Regulatory Compliance”

• The high cost of advanced ophthalmic surgical devices poses a challenge for smaller clinics and budget-conscious healthcare facilities, limiting widespread adoption across Belgium
• For instance, premium laser-assisted cataract systems and high-end phacoemulsification machines often require substantial capital investment, which can be a barrier for hospitals with constrained budgets
• Strict regulatory approvals and compliance requirements for medical devices increase the complexity and time required to launch new ophthalmic products in Belgium, potentially delaying market entry
• In addition, maintenance costs, specialized training requirements, and the need for dedicated surgical staff further contribute to adoption challenges, particularly for newer or smaller clinics
• Overcoming these challenges through cost-optimized devices, leasing models, and training programs will be critical to ensure sustained growth. For instance, some companies now offer bundled training and service contracts to facilitate smoother adoption in Belgian hospitals
• Limited local manufacturing of ophthalmic devices in Belgium increases reliance on imports, exposing hospitals to price fluctuations and supply chain disruptions. For instance, delays in shipment of high-end IOL systems have occasionally impacted surgical schedules
• Resistance to adopting new technologies among traditional surgeons or clinics with legacy equipment can slow market penetration. For instance, some smaller clinics prefer conventional phacoemulsification systems over advanced laser-assisted units due to familiarity and training requirements

Belgium Ophthalmic Surgical Devices Market Scope

The market is segmented on the basis of product type, disease type, surgery devices, and end user.

•  By Product Type

On the basis of product type, the Belgium ophthalmic surgical devices market is segmented into implants, consumables, and equipment. The implants segment dominated the market with the largest revenue share of 52.3% in 2025, driven by the critical role of intraocular lenses (IOLs) in cataract surgeries and their growing adoption across hospitals and specialized eye clinics. IOL implants are preferred for their ability to restore vision effectively, with advanced designs catering to presbyopia, astigmatism, and other refractive errors. Hospitals and ophthalmic centers prioritize high-quality implants to achieve better post-operative outcomes and patient satisfaction. In addition, the consistent prevalence of cataracts and other age-related ocular disorders in Belgium ensures steady demand. Technological advancements such as toric and multifocal IOLs further strengthen this segment’s dominance.

The consumables segment is anticipated to witness the fastest growth rate of 19.8% from 2026 to 2033, driven by increasing use of surgical viscoelastics, disposable phaco tips, and sterile drapes that support efficiency and safety in ophthalmic procedures. Consumables are critical for ensuring hygiene and minimizing infection risk during surgeries. Rising surgical volumes, particularly for cataract and glaucoma procedures, boost demand for consumables. In addition, the trend of outpatient and day-care ophthalmic procedures increases reliance on disposable consumables. Their recurring purchase nature contributes to sustained market growth. Clinics also prefer high-quality consumables to improve surgical precision and patient recovery.

•  By Disease Type

On the basis of disease type, the market is segmented into glaucoma, retinal diseases, dry eye disease, allergy & infections, and others. The glaucoma segment dominated the market with a revenue share of 33.7% in 2025, due to the high prevalence of glaucoma among the aging Belgian population and increasing need for surgical interventions to manage intraocular pressure. Hospitals and ophthalmic clinics invest heavily in trabeculectomy devices, micro-stents, and laser-assisted tools to manage glaucoma progression effectively. Early diagnosis and increasing awareness about vision preservation are contributing to the demand for surgical solutions. In addition, innovations in minimally invasive glaucoma surgery (MIGS) devices improve patient compliance and post-operative outcomes. Glaucoma surgeries are often recurring, ensuring continued device usage. Rising government and private healthcare initiatives targeting glaucoma awareness further reinforce this segment’s dominance.

The retinal diseases segment is expected to witness the fastest CAGR of 20.5% from 2026 to 2033, fueled by the rising prevalence of diabetic retinopathy, age-related macular degeneration, and retinal detachments. Advanced vitreoretinal devices, including micro-incision vitrectomy systems and retinal laser platforms, are driving adoption. Belgium’s expanding elderly population and increasing incidence of diabetes contribute to higher surgical demand. Retinal surgeries are highly specialized, requiring sophisticated instruments, boosting market potential. Continuous R&D and adoption of high-precision imaging-guided tools also accelerate growth. Ophthalmic centers are increasingly investing in these devices to cater to growing patient demand efficiently.

•  By Surgery Devices

On the basis of surgery devices, the market is segmented into cataract surgery devices, refractive surgery devices, glaucoma surgery devices, and vitreoretinal surgery devices. The cataract surgery devices segment dominated the market with a share of 45.6% in 2025, driven by the high incidence of cataracts in Belgium and the central role of phacoemulsification systems and femtosecond lasers in treatment. Cataract surgeries are among the most commonly performed ophthalmic procedures, ensuring steady demand for advanced devices. The adoption of premium IOLs, improved surgical techniques, and outpatient surgery settings contribute to market stability. Hospitals and clinics prioritize devices offering higher precision, reduced recovery time, and better patient outcomes. Continuous innovation in laser-assisted cataract surgery strengthens the segment’s dominance. Government and private healthcare initiatives supporting eye care for aging populations further drive adoption.

The refractive surgery devices segment is anticipated to witness the fastest growth rate of 18.9% from 2026 to 2033, driven by increasing demand for laser-based vision correction procedures such as LASIK and SMILE. Rising awareness about refractive error correction and increasing affordability of laser treatments boost adoption. Clinics are investing in advanced excimer and femtosecond laser systems to meet patient expectations for minimally invasive, precise surgeries. Younger populations seeking freedom from glasses and contact lenses fuel demand. Technological upgrades improving safety and reducing post-operative complications enhance the segment’s growth. In addition, private ophthalmic clinics actively promote premium refractive procedures, further accelerating market expansion.

• By End User

On the basis of end user, the market is segmented into hospitals, ophthalmic clinics, and others. The hospitals segment dominated the market with a revenue share of 57.4% in 2025, as hospitals serve as the primary centers for high-volume cataract, glaucoma, and retinal surgeries. Hospitals have the infrastructure, skilled surgeons, and advanced equipment to perform complex ophthalmic procedures. They prioritize investments in technologically advanced surgical devices to improve outcomes, reduce complications, and enhance operational efficiency. Integration of devices with hospital digital systems allows streamlined patient management. Hospitals also benefit from bulk purchasing and long-term service contracts, ensuring consistent device utilization. High patient inflow, particularly from aging populations, strengthens the segment’s dominance.

The ophthalmic clinics segment is expected to witness the fastest CAGR of 21.1% from 2026 to 2033, driven by the rising number of specialized outpatient eye centers performing cataract, refractive, and laser-assisted procedures. Clinics focus on patient convenience, quick recovery, and cost-effective treatments. Increased adoption of portable and compact devices allows these clinics to expand surgical capabilities efficiently. Private clinics also emphasize premium procedures such as laser refractive surgery, boosting device demand. The trend of preventive eye care and routine screenings further increases patient footfall. Strategic partnerships with device manufacturers offering training and support accelerate adoption in this segment.

Belgium Ophthalmic Surgical Devices Market Share

The Belgium Ophthalmic Surgical Devices industry is primarily led by well-established companies, including:

• Alcon Inc. (Switzerland)
• Carl Zeiss Meditec AG (Germany)
• Johnson & Johnson Services, Inc. (U.S.)
• Bausch + Lomb Incorporated (U.S.)
• HASA OPTIX (Belgium)
• Eurocrystal (Belgium)
• STAAR Surgical Company (U.S.)
• Ophtec BV (Netherlands)
• Takagi Ophthalmic Instruments Europe Ltd (U.K.)
• BVI Medical (U.S.)
• TELEON GmbH (Germany)
• Rockmed (Belgium)
• Simovision BV (Netherlands)
• NEWLEAF OPHTHALMOLOGY BV (Belgium)
• NIDEK Co., Ltd. (Japan)
• Topcon Corporation (Japan)
• Heidelberg Engineering GmbH (Germany)
• Aurolab (India)
• AST Products, Inc. (U.S.)
• HEINE Optotechnik GmbH & Co.KG (Germany)

What are the Recent Developments in Belgium Ophthalmic Surgical Devices Market?

• In September 2025, BVI announced the European debut unveiling of its Virtuoso® dual‑function phaco‑vitrectomy surgical system, a next‑generation platform designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal procedures, marking a significant technological milestone for ophthalmic surgery in Belgium and wider Europe
• In May 2025, Intalight received CE mark approval for its DREAM OCT™ swept‑source imaging platform, enabling commercialisation of this high‑performance optical coherence tomography (OCT) system across the European Union, including Belgium, which enhances retina and anterior segment imaging quality in clinical and research ophthalmology
• In May 2025, Medical DevEyes Belgium reported that its partner Intalight’s DREAM OCT™ received CE Mark approval, confirming readiness for clinical deployment and offering Belgian eye care professionals access to next‑generation ultra‑widefield imaging capabilities for complex retinal diagnostics
• In July 2023, BVI expanded its intraocular lens (IOL) R&D and manufacturing capacity with a new state‑of‑the‑art facility in Liège, Belgium, significantly increasing production and reinforcing the country’s role in global ophthalmic innovation and precision ophthalmic implant development
• In January 2021, Alcon Inc. announced the launch of its AcrySof IQ Vivity presbyopia‑mitigating IOL, targeting enhanced vision outcomes for cataract patients, strengthening product offerings accessible to Belgian surgeons and patients through regional distributors and clinics

SKU-63727